MREO

Mereo Biopharma

• PR Newswire·2d ago

  MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

• PR Newswire·03/31 22:37

  MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

• PR Newswire·03/28 14:03

  MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

• TipRanks·03/27 12:15

  Mereo Biopharma Announces Upcoming Board Change, Ensuring Continuity

• TipRanks·03/26 12:21

  Analysts Conflicted on These Healthcare Names: Erasca (ERAS) and Mereo Biopharma Group Plc (MREO)

• TipRanks·03/24 11:16

  Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

• Seeking Alpha·03/23 16:48

  Mereo downgraded at JP Morgan on setrusumab regulatory uncertainty

• Dow Jones·03/23 12:50

  Mereo BioPharma Group Cut to Neutral From Overweight by JP Morgan

• TipRanks·03/23 09:10

  Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

• TipRanks·03/20 20:50

  Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

• PR Newswire·03/20 18:24

  MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

• TipRanks·03/20 11:05

  Mereo Biopharma Group Plc (MREO) Receives a Rating Update from a Top Analyst

• TipRanks·03/20 11:00

  Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Solid Biosciences (SLDB) and Mereo Biopharma Group Plc (MREO)

• TipRanks·03/19 19:15

  Balanced Risk-Reward Amid Clinical Uncertainty: Maintaining Hold on Mereo BioPharma

• Seeking Alpha·03/19 18:51

  Mereo BioPharma Group reports FY results